Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.00081 | 1 |
mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.00075 | 1 |
mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.0009 | 1 |
mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.00078 | 1 |
mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.00075 | 1 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00053 | 1 |
mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.0004 | 1 |